Journal of Clinical Pediatrics >
Analysis of prognostic risk factors of IgA vasculitis with nephritis in children
Received date: 2023-07-31
Online published: 2023-12-04
IgA vasculitis (IgAV) is the most common systemic small vessel vasculitis in children, and it is called IgA vasculitis with nephritis (IgAVN) when it affects the kidneys. Renal damage eventually lead to chronic kidney disease in about 20% children with IgAVN, and accounting for 1%~2% of all childhood end-stage renal disease (ESRD). Therefore, it is important to identify the risk factors for the prognosis of IgAVN in children and give timely and effective intervention for the prognosis of IgAVN. This article reviews the risk factors affecting the prognosis of IgAVN in children, in order to provide reference for clinical decision-making.
Key words： IgA vasculitis; IgA vasculitis with nephritis; prognosis; risk factor; child
Xiaojing NIE , Yi CHEN . Analysis of prognostic risk factors of IgA vasculitis with nephritis in children[J]. Journal of Clinical Pediatrics, 2023 , 41(12) : 895 -902 . DOI: 10.12372/jcp.2023.23e0697
| [1] | Davin JC, Coppo R. Henoch-Sch?nlein purpura nephritis in children[J]. Nat Rev Nephrol, 2014, 10(10): 563-573. |
| [2] | Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international Chapel Hill consensus conference nomen-clature of vasculitides[J]. Arthritis Rheum, 2013, 65(1): 1-11. |
| [3] | Oni L, Sampath S. Childhood IgA vasculitis (Henoch Sch?nlein Purpura)-advances and knowledge gaps[J]. Front Pediatr, 2019, 7: 257. |
| [4] | Calvi?o MC, Llorca J, García-Porrúa C, et al. Henoch-Sch?nlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study[J]. Medicine (Baltimore), 2001, 80(5): 279-290. |
| [5] | Calvo-Río V, Loricera J, Mata C, et al. Henoch-Sch?nlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center[J]. Medicine (Baltimore), 2014, 93(2): 106-113. |
| [6] | Kang Y, Park JS, Ha YJ, et al. Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Sch?nlein purpura[J]. J Korean Med Sci, 2014, 29(2): 198-203. |
| [7] | Trapani S, Micheli A, Grisolia F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature[J]. Semin Arthritis Rheum, 2005, 35(3): 143-153. |
| [8] | Soylemezoglu O, Ozkaya O, Ozen S, et al. Henoch-Sch?nlein nephritis: a nationwide study[J]. Nephron Clin Pract, 2009, 112(3): c199-c204. |
| [9] | Nong BR, Huang YF, Chuang CM, et al. Fifteen-year experience of children with Henoch-Sch?nlein purpura in southern Taiwan, 1991-2005[J]. J Microbiol Immunol Infect, 2007, 40(4): 371-376. |
| [10] | Goldstein AR, White RH, Akuse R, et al. Long-term follow-up of childhood Henoch-Sch?nlein nephritis[J]. Lancet, 1992, 339(8788): 280-282. |
| [11] | Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Sch?nlein purpura: a retrospective cohort study[J]. Lancet, 2002, 360(9334): 666-670. |
| [12] | Gardner-Medwin JMM, Dolezalova P, Cummins C, et al. Incidence of Henoch-Sch?nlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins[J]. Lancet, 2002, 360(9341): 1197-1202. |
| [13] | Kang Z, Xun M, Li Z, et al. Association of the clinicopathological characteristics and proteinuria remission of pediatric IgAV with nephrotic-range proteinuria: a retrospective cohort study[J]. Front Pediatr, 2022, 10: 959212. |
| [14] | Kurt-?ükür ED, Sekar T, Tullus K. Biopsy-proven Henoch-Sch?nlein purpura nephritis: a single center experience[J]. Pediatr Nephrol, 2021, 36(5): 1207-1215. |
| [15] | 李华荣, 陈朝英, 涂娟, 等. 儿童紫癜性肾炎预后不良相关因素分析[J]. 中华肾脏病杂志, 2020, 36(7): 535-542. |
| [16] | Taal MW, Brenner BM. Renal risk scores: progress and prospects[J]. Kidney Int, 2008, 73(11): 1216-1219. |
| [17] | Verhave JC, Gansevoort RT, Hillege HL, et al. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population[J]. Kidney Int Suppl, 2004, 66(92):S18-S21. |
| [18] | Iseki K, Ikemiya Y, Iseki C, et al. Proteinuria and the risk of developing end-stage renal disease[J]. Kidney Int, 2003, 63(4): 1468-1474. |
| [19] | Piram M, Maldini C, Biscardi S, et al. Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis: a population-based study[J]. Rheumatology (Oxford), 2017, 56(8): 1358-1366. |
| [20] | Shi M, Yu S, Ouyang Y, et al. Increased lifetime risk of ESRD in familial IgA nephropathy[J]. Kidney Int Rep, 2021, 6(1) : 91-100. |
| [21] | Kiryluk K, Moldoveanu Z, Sanders J T, et al. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Sch?nlein purpura nephritis[J]. Kidney Int, 2011, 80(1): 79-87. |
| [22] | Mir S, Yavascan O, Mutlubas F, et al. Clinical outcome in children with Henoch-Sch?nlein nephritis[J]. Pediatr Nephrol, 2007, 22(1): 64-70. |
| [23] | 冯丹, 郝胜, 钮小玲, 等. 儿童紫癜性肾炎预后的相关因素分析[J]. 中华实用儿科临床杂志, 2016, (9): 679-682. |
| [24] | Counahan R, Winterborn MH, White RH, et al. Prognosis of Henoch-Sch?nlein nephritis in children[J]. Br Med J, 1977, 2(6078): 11-14. |
| [25] | Algoet C, Proesmans W. Renal biopsy 2-9 years after Henoch Sch?nlein purpura[J]. Pediatr Nephrol, 2003, 18(5): 471-473. |
| [26] | Wakaki H, Ishikura K, Hataya H, et al. Henoch-Sch?nlein purpura nephritis with nephrotic state in children: predictors of poor outcomes[J]. Pediatr Nephrol, 2011, 26(6): 921-925. |
| [27] | 刘钧菲, 王华. 过敏性紫癜患儿抗凝纤溶系统标志物的动态变化[J]. 临床儿科杂志, 2012, 30(6): 547-551. |
| [28] | 李雪倩, 刘小荣, 姚兴凤, 等. 牛津分类与国际小儿肾脏病研究组分级在评价儿童紫癜性肾炎预后中的应用[J]. 中华肾脏病杂志, 2020, 36(1): 26-33. |
| [29] | 中华医学会儿科学分会肾脏学组. 紫癜性肾炎诊治循证指南(2016)[J]. 中华儿科杂志, 2017, 55 (9): 647-651. |
| [30] | Davin JC. Henoch-Sch?nlein purpura nephritis: pathophysiology, treatment, and future strategy[J]. Clin J Am Soc Nephrol, 2011, 6(3): 679-689. |
| [31] | Jelusic M, Sestan M, Cimaz R, et al. Different histological classifications for Henoch-Sch?nlein purpura nephritis: which one should be used?[J]. Pediatr Rheumatol Online J, 2019, 17(1): 10. |
| [32] | Edstr?m Halling S, S?derberg MP, Berg UB. Predictors of outcome in Henoch-Sch?nlein nephritis[J]. Pediatr Nephrol, 2010, 25(6): 1101-1108. |
| [33] | Coppo R, Andrulli S, Amore A, et al. Predictors of outcome in Henoch-Sch?nlein nephritis in children and adults[J]. Am J Kidney Dis, 2006, 47(6) : 993-1003. |
| [34] | Roberts ISD, Cook HT, Troyanov S, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility[J]. Kidney Int, 2009, 76(5): 546-556. |
| [35] | Trimarchi H, Barratt J, Cattran DC, et al. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group[J]. Kidney Int, 2017, 91(5): 1014-1021. |
| [36] | Yun D, Kim DK, Oh KH, et al. MEST-C pathological score and long-term outcomes of child and adult patients with Henoch-Sch?nlein purpura nephritis[J]. BMC Nephrol, 2020, 21(1): 33. |
| [37] | Wang M, Wang R, He X, et al. Using MEST-C scores and the international study of kidney disease in children classification to predict outcomes of Henoch-Sch?nlein purpura nephritis in children[J]. Front Pediatr, 2021, 9: 658845. |
| [38] | Delbet JD, Geslain G, Auger M, et al. Histological prognostic factors in children with Henoch-Sch?nlein purpura nephritis[J]. Pediatr Nephrol, 2020, 35(2): 313-320. |
| [39] | Koskela M, Ylinen E, Ukonmaanaho EM, et al. The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch-Sch?nlein purpura nephritis[J]. Pediatr Nephrol, 2017, 32(7): 1201-1209. |
| [40] | Zhong X, Ding J. Diagnosis and treatment of IgA nephropathy and IgA vasculitis nephritis in Chinese children[J]. Pediatr Nephrol, 2023, 38(6): 1707-1715. |
| [41] | Delbet JD, Parmentier C, Herbez Rea C, et al. Management of IgA vasculitis with nephritis[J]. Paediatr Drugs, 2021, 23(5): 425-435. |
| [42] | Deki S, Hamada R, Mikami N, et al. Half of children with IgA vasculitis-associated nephritis with nephrotic state spontaneously recover[J]. Nephrology (Carlton), 2022, 27(8): 681-689. |
| [43] | Davin JC, Coppo R. Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch-Sch?nlein purpura nephritis[J]. Pediatr Nephrol, 2013, 28(10): 1897-1903. |
| [44] | Ozen S, Marks SD, Brogan P, et al. European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative[J]. Rheumatology (Oxford), 2019, 58(9): 1607-1616. |
| [45] | Kawasaki Y, Suzuki J, Nozawa R, et al. Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Sch?nlein nephritis[J]. Pediatrics, 2003, 111(<W>4 Pt 1):785-789. |
| [46] | Song Y, Huang X, Yu G, et al. Pathogenesis of IgA vasculitis: an up-to-date review[J]. Front Immunol, 2021, 12: 771619. |
| [47] | Novak J, Rizk D, Takahashi K, et al. New insights into the pathogenesis of IgA nephropathy[J]. Kidney Dis (Basel), 2015, 1(1): 8-18. |
| [48] | Zhao N, Hou P, Lv J, et al. The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression[J]. Kidney Int, 2012, 82(7): 790-796. |
| [49] | Heineke MH, Ballering AV, Jamin A, et al. New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Sch?nlein purpura)[J]. Autoimmun Rev, 2017, 16(12): 1246-1253. |
| [50] | Launay P, Grossetête B, Arcos-Fajardo M, et al. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice[J]. J Exp Med, 2000, 191(11): 1999-2009. |
| [51] | Vuong MT, Hahn-Zoric M, Lundberg S, et al. Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy[J]. Kidney Int, 2010, 78(12): 1281-1287. |
| [52] | Davin JC, Ten Berge IJ, Weening JJ. What is the difference between IgA nephropathy and Henoch-Sch?nlein purpura nephritis?[J]. Kidney Int, 2001, 59(3): 823-834. |
| [53] | Yang YH, Tsai IJ, Chang CJ, et al. The interaction between circulating complement proteins and cutaneous microvascular endothelial cells in the development of childhood Henoch-Sch?nlein Purpura[J]. PLoS One, 2015, 10(3): e0120411. |
| [54] | Dumont C, Mérouani A, Ducruet T, et al. Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-Sch?nlein purpura[J]. Pediatr Nephrol, 2020, 35(5): 843-850. |
| [55] | Takemura T, Yoshioka K, Murakami K, et al. Cellular localization of inflammatory cytokines in human glomerulonephritis[J]. Virchows Arch, 1994, 424(5): 459-464. |
| [56] | Del Vecchio GC, Penza R, Altomare M, et al. Cytokine pattern and endothelium damage markers in Henoch-Sch?nlein purpura[J]. Immunopharmacol Immunotoxicol, 2008, 30(3): 623-629. |
| [57] | Wu H, Wen Y, Yue C, et al. Serum TNF-α level is associated with disease severity in adult patients with immunoglobulin A vasculitis nephritis[J]. Dis Markers, 2020: 1-7. |
| [58] | Wang K, Sun X, Jing S, et al. Development and validation of nomogram prediction model for severe kidney disease in children with Henoch-Sch?nlein purpura: A prospective analysis of two independent cohorts-forecast severe kidney disease outcome in 2,480 hospitalized Henoch-Sch?nlein purpura children[J]. Front Immunol, 2022, 13: 999491. |
| [59] | He M, Li C, Kang Y, et al. Clinical predictive model for the 1-year remission probability of IgA vasculitis nephritis[J]. Int Immunopharmacol, 2021, 101(Pt B): 108341. |
| [60] | Song Z, Nie Y, Yang L, et al. Predicting severe renal and gastrointestinal involvement in childhood immunoglobulin A vasculitis with routine laboratory parameters[J]. Dermatology, 2022, 238(4): 745-752. |
| [61] | Wang J, Chu H, Pan Y. Prediction of renal damage in children with IgA vasculitis based on machine learning[J]. Medicine (Baltimore), 2022, 101(42): e31135. |
/
| 〈 |
|
〉 |
